Healthcare providers should offer risk-reducing medications such as tamoxifen, raloxifene and aromatase inhibitors to women at an increased risk of breast cancer or low risk of experiencing adverse effects, according to the U.S. Preventive Services Task Force (USPSTF).

The FDA released a statement, Thursday, Aug. 29, recommending duodenoscope manufacturers and health care facilities begin transitioning to new, innovate scopes that are less risky to patients.

California workers from Kaiser Permanente are planning to protest the healthcare organization’s labor practices on Sept. 2. The Labor Day protest comes just before more than 80,000 unionized workers plan to strike in October.

A proposed settlement would see Purdue Pharma shell out between $10 billion and $12 billion to close thousands of lawsuits over the company’s role in the opioid abuse and overdose epidemic.

With nearly 200 vaping-related lung disease injuries and one death across the U.S., the CDC’s investigation into e-cigarette harms is highlighting just how unregulated the market is for these relatively new tobacco and marijuana products, Politico reported.

Physician compensation increased by a median of 2.92% in 2018, according to a new survey from AMGA Consulting. That’s a big jump from the 0.89% increase in compensation the previous year, reflecting that demand for healthcare professionals is driving higher pay.

Pharmaceutical, medical device and consumer packaged goods company Johnson & Johnson has been ordered to pay $572 million to the state of Oklahoma after a judge found the company downplayed the dangers of its opioid painkillers and contributed to the opioid overdose epidemic in the state.

While there is some back-and-forth debate over the true savings results from Medicare Advantage, the plans could actually cost Medicare and the American taxpayer.